INDICATIONS
Letra 2.5 is indicated in the treatment of breast cancer in post menopausal women who have received five years of adjuvant Tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
INGREDIENT
Letrozole 2.5mg
PRESENTATION
Each bottle contains 50 tablets of 2.5mg per tablet.
